Effect of mizolastine on visceral sensory afferent sensitivity and inflammation during experimental colitis.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 9541730)

Published in Arzneimittelforschung on February 01, 1998

Authors

J Goldhill1, P Pichat, N Roome, I Angel, S Arbilla

Author Affiliations

1: Synthélabo Recherche, Rueil-Malmaison France.

Articles by these authors

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? Br J Pharmacol (2011) 1.19

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. J Pharmacol Exp Ther (1988) 1.10

Expression of alpha 1-adrenoceptor subtypes in rat tissues: implications for alpha 1-adrenoceptor classification. Eur J Pharmacol (1994) 1.05

Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.04

Morphine and beta-endorphin inhibit release of noradrenaline from cerebral cortex but not of dopamine from rat striatum. Nature (1978) 1.03

ATP-stimulated Ca2+ transport into cholinergic Torpedo synaptic vesicles. J Neurochem (1980) 1.00

Determination of delta pH in cholinergic synaptic vesicles: its effect on storage and release of acetylcholine. Life Sci (1980) 0.95

Differences between presynaptic and postsynaptic alpha-adrenoceptors in the isolated nictitating membrane of the cat: effects of metanephrine and tolazoline. Br J Pharmacol (1978) 0.95

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.93

gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor. J Pharmacol Exp Ther (1982) 0.93

Analysis of alpha1-adrenoceptors in rabbit lower urinary tract and mesenteric artery. Eur J Pharmacol (1997) 0.92

Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes. Pharmacol Biochem Behav (1988) 0.91

Bacterial studies of the Papillon-Lefévre syndrome. J Dent Res (1977) 0.90

Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists. J Pharmacol Exp Ther (1997) 0.89

Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets. J Pharmacol Exp Ther (1990) 0.89

High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptors. Eur J Pharmacol (1986) 0.87

SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons. Neurosci Lett (1992) 0.85

Determination of delta psi, delta pH and the proton electrochemical gradient in isolated cholinergic synaptic vesicles. Life Sci (1981) 0.84

Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes. Adv Biochem Psychopharmacol (1990) 0.84

Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system. J Pharmacol Exp Ther (1992) 0.84

Autoradiographic localization of [3H]zolpidem binding sites in the rat CNS: comparison with the distribution of [3H]flunitrazepam binding sites. J Neurochem (1987) 0.83

Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.83

Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol (1986) 0.83

The response of rat colonic mucosa to 5-hydroxytryptamine in health and following restraint stress. Eur J Pharmacol (1998) 0.83

Chronic sympathetic denervation increases muscarinic cholinoceptor binding in the rat submaxillary gland. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.82

Stereoselectivity of presynaptic autoreceptors modulating dopamine release. Eur J Pharmacol (1981) 0.82

Expression and properties of recombinant alpha 1 beta 2 gamma 2 and alpha 5 beta 2 gamma 2 forms of the rat GABAA receptor. Eur J Pharmacol (1993) 0.82

Functional uroselectivity. Eur Urol (1998) 0.82

Selectivity for omega-receptor subtypes as a strategy for the development of anxiolytic drugs. Pharmacopsychiatry (1990) 0.81

Effects of alfuzosin on urethral and blood pressures in conscious male rats. Life Sci (1995) 0.81

Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig. Eur J Pharmacol (1998) 0.81

Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. J Pharmacol Exp Ther (1987) 0.81

Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex. Life Sci (1978) 0.81

Acute inescapable stress exposure induces long-term sleep disturbances and avoidance behavior: a mouse model of post-traumatic stress disorder (PTSD). Behav Brain Res (2011) 0.81

Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine. J Pharmacol Exp Ther (1981) 0.81

Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.80

Presynaptic GABA autoreceptors on GABAergic nerve endings of the rat substantia nigra. Eur J Pharmacol (1979) 0.79

Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat. Arzneimittelforschung (1998) 0.79

Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. J Pharmacol Exp Ther (1985) 0.79

Rapid desensitization of presynaptic dopamine autoreceptors during exposure to exogenous dopamine. Brain Res (1985) 0.79

Modulation of the electrically evoked release of 5-[3H]hydroxytryptamine from rat cerebral cortex: effects of alpidem, CL 218872, and diazepam. J Neurochem (1988) 0.79

The adrenergic, cholinergic and NANC nerve-mediated contractions of the female rabbit bladder neck and proximal, medial and distal urethra. Br J Pharmacol (1998) 0.79

Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. J Pharmacol Exp Ther (1983) 0.79

Adrenergic and nonadrenergic cotransmitters inhibit insulin secretion during sympathetic stimulation in dogs. Am J Physiol (1992) 0.79

Limitations of the benzodiazepine receptor nomenclature: a proposal for a pharmacological classification as omega receptor subtypes. Fundam Clin Pharmacol (1988) 0.78

Saturable acetylcholine transport into purified cholinergic synaptic vesicles. Proc Natl Acad Sci U S A (1981) 0.78

Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro. Br J Pharmacol (1981) 0.78

A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3H]-serotonin from the rat substantia nigra. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.78

Quantitative evaluation by immunocytochemistry of the age-related variations in thyroid C cells in the rat. Acta Anat (Basel) (1990) 0.78

Concomitant decrease in [3H]imipramine binding in cat brain and platelets after chronic treatment with imipramine. Eur J Pharmacol (1982) 0.78

Inhibition of insulin release induced by galanin in the dog is not exclusively mediated by activation of ATP-sensitive K+ channels. Pharmacology (1993) 0.78

Purification by affinity chromatography of nicotonic and muscarinic hydrophobic proteins separated by Sephadex LH20. Biochem Biophys Res Commun (1975) 0.78

Presynaptic receptors on peripheral noradrenergic neurons. Ann N Y Acad Sci (1990) 0.78

Predominant microbiota associated with periodontal health in the aged. J Periodontol (1978) 0.78

Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations. Life Sci (1998) 0.78

On the regulation of acetylcholine release: a study utilizing Torpedo synaptosomes and synaptic vesicles. J Physiol (Paris) (1980) 0.78

Differential effects of the stereoisomers of 3PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.77

[3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease. J Neurochem (1987) 0.77

Binding of [3H]cirazoline to an imidazoline site in rat brain and kidney membranes. Eur J Pharmacol (1995) 0.77

[3H]cirazoline as a tool for the characterization of imidazoline sites. Ann N Y Acad Sci (1995) 0.77

Inhibition of the electrically evoked release of [3H]acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission. J Neurochem (1985) 0.77

Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77

Decreased central GABA B receptor binding sites in diabetic rats. Neuropsychobiology (1988) 0.77

Post-synaptic 5-HT4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae. Eur J Pharmacol (1997) 0.77

Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats. Life Sci (1996) 0.76

Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding. Brain Res Bull (1986) 0.76

Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum. Effects on 3H-acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.76

Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex. Eur J Pharmacol (1980) 0.76

SL 84.0418: a novel, potent and selective alpha-2 adrenoceptor antagonist: in vitro pharmacological profile. J Pharmacol Exp Ther (1992) 0.76

Decreased GABA B receptors in helpless rats: reversal by tricyclic antidepressants. Neuropsychobiology (1989) 0.76

Characterization of [3H]mazindol binding in rat brain: sodium-sensitive binding correlates with the anorectic potencies of phenylethylamines. J Neurochem (1987) 0.76

Glucostatic regulation of (+)-[3H]amphetamine binding in the hypothalamus: correlation with Na+,K+-ATPase activity. Proc Natl Acad Sci U S A (1985) 0.76

Inhibition of synaptosomal 5-[3H]hydroxytryptamine uptake by endogenous factor(s) in human blood. FEBS Lett (1984) 0.76

Clinical uroselectivity: evidence from patients treated with slow release alfuzosin for symptomatic benign prostatic obstruction. Br J Urol (1998) 0.75

The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis. Pharmacol Biochem Behav (2012) 0.75

Effects of gamma-aminobutyric acid on the potassium and tyramine induced release of [3Hi1-noradrenaline from rat occipital cortex slices [proceedings]. Br J Pharmacol (1978) 0.75

Characterisation of the 5-HT receptor potentiating neurotransmission in rabbit bladder. Eur J Pharmacol (1996) 0.75

Critical analysis of the histomorphometry of rat thyroid after treatment with thyroxin and propylthiouracil. Ann Rech Vet (1991) 0.75

Inhibition by yohimbine of the calcium-dependent evoked release of [3H]GABA in rat and mouse brain slices in vitro. Eur J Pharmacol (1985) 0.75

Electrical stimulation releases 3H-betaxolol from rat atrial slices: possible role of noradrenergic nerves. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.75

The imidazoline SL 84.0418 shows stereoselectivity in blocking alpha 2-adrenoceptors but not ATP-sensitive K+ channels in pancreatic B-cells. Eur J Pharmacol (1994) 0.75

Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum. Prog Clin Biol Res (1985) 0.75

Antagonism of presynaptic dopamine receptors by phenothiazine drug metabolites. Life Sci (1990) 0.75

The facilitation by diazepam of the electrically evoked release of [3H]5-HT from rat cortical slices is antagonized by picrotoxin and Ro 5-4864. Eur J Pharmacol (1988) 0.75

[A specific domain (the omega 1 site) of the GABA(A) receptor may be implicated in the hypnotic effects of zolpidem]. Encephale (1990) 0.75

Phenylethylamine-induced release of noradrenaline fails to stimulate alpha 1-adrenoceptors modulating [3H]-acetylcholine release in rat atria, but activates alpha 2-adrenoceptors modulating [3H]-serotonin release in the hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.75

Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines. Eur J Pharmacol (1985) 0.75

Newly synthesized noradrenaline mediates the alpha 2-adrenoceptor inhibition of [3H]5-hydroxytryptamine release induced by beta-phenylethylamine in rat hippocampal slices. Eur J Pharmacol (1986) 0.75

Alpha 2-adrenoceptors and the regulation of glucose, insulin and amylin levels in diabetic rats. Life Sci (1995) 0.75

The serotonin re-uptake transporter as a target for antidepressant action. Clin Neuropharmacol (1992) 0.75

Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity. Psychopharmacology Suppl (1985) 0.75

Glucose regulates [3H](+)-amphetamine binding and Na+K+ ATPase activity in the hypothalamus: a proposed mechanism for the glucostatic control of feeding and satiety. Brain Res Bull (1986) 0.75

Site of action of anorectic drugs: glucoprivic- versus food deprivation-induced feeding. Pharmacol Biochem Behav (1987) 0.75

In vitro stimulation of insulin release by SL 84.0418, a new alpha 2-adrenoceptor antagonist. Eur J Pharmacol (1994) 0.75

Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery. J Neural Transm Suppl (1991) 0.75

[3H] beta-phenylethylamine but not [3H](+)-amphetamine is released by electrical stimulation from perfused rat striatal slices. Eur J Pharmacol (1985) 0.75

Supersensitivity of alpha 2-adrenoceptors modulating [3H]5-HT release after noradrenergic denervation with DSP4. Eur J Pharmacol (1985) 0.75